Alpha Tau Medical

Alpha Tau Medical company information, Employees & Contact Information

Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide. Alpha DaRT Breakthrough Cancer Treatment Alpha DaRT enables high-precision alpha radiation for all types of solid tumors. The treatment is delivered by inserting with Radium-224 impregnated seeds into the tumor. When the Radium decays, its short-lived daughters are released from the seed, disperse into the tumor and emit high-energy alpha particles which destroy the tumor. Since the alpha-emitting atoms hardly diffuse in healthy tissue, the Alpha DaRT mainly affects the tumor, sparing the healthy tissue around it. Alpha DaRT has several important advantages: • Highly potent and conformal • Proven efficacy for all solid tumors tested • Enhances systemic anti-tumor immune response • Effective regardless of tumor oxygen level • Short half-life – quick clinical outcome • No known negative systemic effects • Single-session treatment • Enables combination with other therapies or reapplication • Disposable applicators - does not require capital equipment or special shielding

Company Details

Employees
103
Founded
-
Address
Kiryat Hamada St 5, Jerusalem,9777605,israel
Phone
+972-3-618-2477
Email
in****@****cal.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Jerusalem
Looking for a particular Alpha Tau Medical employee's phone or email?

Alpha Tau Medical Questions

News

Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology (NASDAQ:DRTS) - Seeking Alpha

Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology (NASDAQ:DRTS) Seeking Alpha

Latham & Watkins Advises Alpha Tau Medical in US$36.9 Million Registered Direct Offering - Latham & Watkins LLP

Latham & Watkins Advises Alpha Tau Medical in US$36.9 Million Registered Direct Offering Latham & Watkins LLP

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - PR Newswire

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical PR Newswire

Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention - Yahoo Finance

Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention Yahoo Finance

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire

Alpha Tau Medical to merge with SPAC at $1 billion valuation to battle cancer - The Times of Israel

Alpha Tau Medical to merge with SPAC at $1 billion valuation to battle cancer The Times of Israel

Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination - PR Newswire

Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination PR Newswire

Top Alpha Tau Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant